Work

Radiotherapy combined with anlotinib for recurrent high-grade soft tissue sarcoma of the scalp: a case report

Year: 2026

Type: article

Abstract: Purpose: Soft tissue sarcoma (STS) is a rare but aggressive mesenchymal malignancy that accounts for less than 1% of all adult cancers. Head and neck soft tissue sarcomas (HNSTS) are infrequent malignant tumors arising from mesenchymal and neuroectodermal tissues in the head and neck region with a poor prognosis, and recurrence is predominantly local. There are few targeted management guidelines. Case description: We report the case of a 77-year-old woman with postoperative recurrence of HNSTS. The patient was diagnosed with high-grade soft tissue sarcoma of the scalp in February 2025 and treated with surgery. In June 2025, the patient was diagnosed with recurrence, and was subsequently treated with combination therapy consisting of the anti-angiogenic inhibitor anlotinib and radiotherapy. In December 2025, after nine cycles, the patient showed a complete response (CR) to therapy. Conclusion: This indicates that radiotherapy combined with anti-angiogenic targeted therapy may produce synergistic effects in patients with HNSTS and provide directions for future clinical decision-making.

Source: Frontiers in Oncology

DOI: 10.3389/fonc.2026.1941568

Authors: Bingxuan Li, Jinling Ren, Xiaoxia Song, Xiaogai Qi

Institution: University of Health and Rehabilitation Sciences

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,801